Opyl Signs Landmark Binding Joint Venture with X Firm Ltd
Melbourne, Australia – Opyl Limited (ASX: OPL or “the Company“) a leader in AI-powered clinical trial optimisation, is thrilled to announce a […]
Opyl Signs New Partnership Agreement with NeuOrphan
TrialKey (ASX: OPL) has entered into a Service Level Agreement (SLA) with Southern Clinical Development Consulting (Southern CDC) to enhance Southern CDC’s capabilities in clinical trial support and optimisation
Opyl Launches AI-Powered AI-Biotech Investment Fund Targeting the US and Australia with Strategic Global Expansion Plans
TrialKey (ASX: OPL) has entered into a Service Level Agreement (SLA) with Southern Clinical Development Consulting (Southern CDC) to enhance Southern CDC’s capabilities in clinical trial support and optimisation
TrialKey Signs Service Level Agreement with Southern Clinical Development Consulting (Southern CDC)
TrialKey (ASX: OPL) has entered into a Service Level Agreement (SLA) with Southern Clinical Development Consulting (Southern CDC) to enhance Southern CDC’s capabilities in clinical trial support and optimisation
Opyl Enters Strategic Partnership with Phenix Health’s The Compendium
Discover TrialKey's non-exclusive strategic partnership with Alithia Life Sciences, a well-recognised CRO specialising in advanced clinical research solutions.
Opyl Enters Strategic Partnership with Alithia Life Sciences
Discover TrialKey's non-exclusive strategic partnership with Alithia Life Sciences, a well-recognised CRO specialising in advanced clinical research solutions.
Opyl Signs MOU with Xco Consortium for EMEA and North America Expansion
We’re thrilled to share some exciting news from Opyl Limited! We’ve just signed a Memorandum of Understanding (MOU) with the Xco consortium, […]
Opyl partners with L39 Capital to launch an AI Biotech Fund leveraging TrialKey
Opyl has partnered with L39 Capital Pty Ltd to launch an AI Biotech Fund in September 2024. This collaboration aims to leverage […]
ARCS Takeaways: AI’s Role in Predicting Clinical Trial Success
The integration of AI in clinical trials represents a significant step towards future-proofing medicine. Through enabling data-driven decisions and optimising trial designs, AI ensures that the healthcare industry adapts to the evolving world.
Transforming Clinical Trials with TrialKey: Insights from EveryDay AI Podcast Episode
Executive Chairman of TrialKey, Saurabh Jain discusses how AI is reshaping clinical trial design and the pivotal role TrialKey plays.
First Trial Gen Revenue and Inaugural Customer: Brain Vector
This engagement with Brain Vector validates the value and effectiveness of our TrialGen platform in real-world clinical settings.
Launch of ‘Trial Gen’ by TrialKey
Announcing the launch of 'Trial Gen' by TrialKey, an innovative module to design clinical trial protocols.
